Navigation Links
PRA Opens Office in Singapore

RALEIGH, N.C., Feb. 23, 2012 /PRNewswire/ -- PRA, a leading Clinical Research Organization, continues our expansion across the burgeoning Asia-Pacific region with the recent opening of an office in Singapore. The office will serve as PRA's central clinical operations location for the region, strengthening the quality and timeliness of our deliverables to sponsors.

The Singapore facility, conveniently located in the heart of the city-state, will provide monitoring, project management, safety reporting, feasibility and other services.

"Building our capability across the region with the center in Singapore permits our sponsors to experience a wider range of services and expertise," said Helen Neal, PRA's Director of Clinical Operations for Asia-Pacific. "This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

Geographically renowned as the region's pharmaceutical and biomedical center, Singapore is the ideal location from which to deliver centralized study support to the region. This city-state serves as an excellent logistics hub with high fluency rates in English, and its government strongly promotes and encourages CROs to conduct cutting-edge clinical research.

"Opening a Singapore office for PRA is an exciting and significant milestone in the company's evolution and is evidence that PRA acknowledges and embraces the full potential that the Asia-Pacific region can bring to the global business going forward," said Ms. Neal.

PRA has been strategically expanding our Asia-Pacific operations since 2000. In addition to Singapore, PRA operates in eight other countries within the region: Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

About PRA   

PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit, email or call our Global Headquarters.

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Stevenage Bioscience Catalyst Opens With Exciting Year Ahead
2. Alchem International Opens Sales and Marketing Office in the U.S.
3. CoreLab Partners Opens Office in Tokyo, Japan
4. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
5. Golden Seeds Opens Office in PLSG Incubator
6. MIABE standard opens up new opportunities in drug discovery
7. Medical Malpractice Insurance Company- Healthcare Providers Insurance Exchange (HPIX) has Expanded its Presence in New Jersey, Opens New Office
8. "Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use
9. New England Biolabs Opens New Subsidiary Office in France
10. New beamline at MAX II opens for research
11. Discovery opens the door to electricity from microbes
Post Your Comments:
(Date:10/12/2015)... This report covers the global cell expansion ... applications, end-user markets and geographic segmentation. Forecasts are provided ... cell expansion market generated revenue of roughly $8.5 billion ... $9.7 billion in 2015 and $22.0 billion by 2020, ... from 2015 to 2020. This report provides: ...
(Date:10/12/2015)... FRANCISCO , October 12, 2015 ... USD 6.49 billion by 2022, according to a new report ... be attributed to rise in incidence of oncology diseases and ... market is expected to reach USD 6.49 billion by ... Inc. This growth in demand can be attributed to rise ...
(Date:10/12/2015)... CITY , Oct. 12, 2015 /PRNewswire/ - Aeterna ... specialty biopharmaceutical company engaged in developing and commercializing novel ... the departure of Dennis Turpin , the Company,s ... decision to close its Quebec City ... Chairman, President and Chief Executive Officer of the Company ...
(Date:10/12/2015)... , October 12, 2015 LabStyle ... Diabetes Management Solution, today announced its Medical Director, Dr. ... study at MobiHealth,s 5th EAI International Conference on ... healthcare through innovations in mobile and wireless technologies," the ... from October 14 - 16, 2015. The ...
Breaking Biology Technology:
(Date:10/5/2015)... 5, 2015 ) ... NXT-ID, Inc. (NASDAQ: NXTD ), a biometric authentication ... --> ) releases the following ... NXTD ), a biometric authentication company focused on the ... Group ( ) releases the following ...
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)... -- The global image sensors market ... by 2020, growing at a CAGR of 4.6% from ... (BSI) technique to improve picture quality are expected to ...      (Logo: , The light falls ... and, thus, reduce the noise interference and increase picture ...
Breaking Biology News(10 mins):